DZIP3 Activators
The category of DZIP3 Activators includes a range of chemical compounds that, while not directly activating DZIP3, can potentially influence its activity through modulation of gene expression, epigenetic regulation, and cellular signaling pathways. DZIP3, a zinc finger protein, is implicated in various cellular processes, and its regulation is closely tied to the broader context of cellular signaling and chromatin dynamics. The first group of these compounds includes epigenetic modulators such as 5-Azacytidine, Trichostatin A, SAHA (Vorinostat), Valproic Acid, BIX-01294, RG108, and Sodium Butyrate. These agents alter DNA methylation and histone modification patterns, leading to changes in chromatin structure, which can subsequently influence the transcriptional regulatory functions of DZIP3. For instance, 5-Azacytidine and RG108, by inhibiting DNA methyltransferases, can lead to changes in DNA methylation status, potentially enhancing the transcriptional activation of genes regulated by DZIP3.
Another significant group comprises compounds that affect cellular signaling and gene expression, including Curcumin, Resveratrol, Lithium Chloride, Retinoic Acid, and Dexamethasone. These substances can influence various signaling pathways and affect transcriptional regulation, potentially impacting the activity of transcription factors like DZIP3. For example, Curcumin and Resveratrol, known for their roles in modulating gene expression and cellular signaling pathways, can potentially influence the regulatory mechanisms in which DZIP3 is involved.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting gene expression and influencing DZIP3. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, can alter chromatin structure and gene expression, potentially affecting DZIP3. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, potentially influencing DZIP3 by altering gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Affects histone modification, potentially influencing DZIP3 expression and function. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
An inhibitor of G9a histone methyltransferase, potentially affecting DZIP3 through epigenetic regulation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, potentially affecting DZIP3 by changing DNA methylation patterns. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Influences multiple cellular pathways, including those related to gene expression, potentially affecting DZIP3. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Affects gene expression and signaling pathways, potentially modulating DZIP3 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt signaling and other pathways, potentially affecting DZIP3. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression, potentially influencing DZIP3 in developmental pathways. | ||||||